Hiroaki Negishi1, Kazuki Nakao1, Michiko Kimura2, Hiroshi Takenaka1, Michiharu Horikawa1. 1. Women's Clinic Ooizumigakuen Higashi-oizumi 1-27-19178-0063 Nerima-ku Tokyo Japan. 2. Department of Obstetrics and Gynecology Saitama Medical College Morohongou 38, Moroyama Town 350-0495 Iruma-gun Saitama Japan.
Abstract
Purpose: To determine the prevalence of insulin resistance (IR) and impaired glucose tolerance (IGT) in PCOS patients, the optimal screening method, and to compare our findings between nonobese and obese Japanese women with PCOS. Methods: Ninety-eight PCOS patients were included in this research from 2006 to 2013. Glucose tolerance test (OGTT) was performed. Serum glucose and insulin concentration were assayed before and 30, 60, and 120 min after taking 75 g of glucose. Results: All examined metabolic parameters were significantly favorable in the nonobese subjects, below 25 kg/m2. HOMA-IR, fasting insulin, glucose120, and insulin120 showed strong correlations with BMI. A total of 1.4 % of nonobese women had IR based on fasting insulin or HOMA-IR. However, 15.5 % (11/71) of nonobese women had IR as determined by a continuous increase of serum insulin level in OGTT. In comparison, the prevalence of IR among the obese women ranged from 41 to 59 %. AUCglucose, glucose60, glucose120, and insulin120 in nonobese women with a continuous insulin increase were higher than those without such a continuous increase. Conclusions: All examined metabolic parameters were significantly correlated with BMI. As the presence of a continuous increase of insulin level reflects to some degree poorer glucose tolerance, delayed insulin secretion, and enhanced insulin response compared with non-continuous insulin increase, OGTT might not been excluded to determine IR and IGT for nonobese women with PCOS.
Purpose: To determine the prevalence of insulin resistance (IR) and impaired glucose tolerance (IGT) in PCOSpatients, the optimal screening method, and to compare our findings between nonobese and obese Japanese women with PCOS. Methods: Ninety-eight PCOSpatients were included in this research from 2006 to 2013. Glucose tolerance test (OGTT) was performed. Serum glucose and insulin concentration were assayed before and 30, 60, and 120 min after taking 75 g of glucose. Results: All examined metabolic parameters were significantly favorable in the nonobese subjects, below 25 kg/m2. HOMA-IR, fasting insulin, glucose120, and insulin120 showed strong correlations with BMI. A total of 1.4 % of nonobese women had IR based on fasting insulin or HOMA-IR. However, 15.5 % (11/71) of nonobese women had IR as determined by a continuous increase of serum insulin level in OGTT. In comparison, the prevalence of IR among the obesewomen ranged from 41 to 59 %. AUCglucose, glucose60, glucose120, and insulin120 in nonobese women with a continuous insulin increase were higher than those without such a continuous increase. Conclusions: All examined metabolic parameters were significantly correlated with BMI. As the presence of a continuous increase of insulin level reflects to some degree poorer glucose tolerance, delayed insulin secretion, and enhanced insulin response compared with non-continuous insulin increase, OGTT might not been excluded to determine IR and IGT for nonobese women with PCOS.
Entities:
Keywords:
Body mass index; Glucose tolerance test; HOMA‐IR; Insulin resistance; PCOS
Authors: Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert Journal: Endocr Rev Date: 2012-07-24 Impact factor: 19.871
Authors: Robert P Kauffman; Vicki M Baker; Pamela Dimarino; Terry Gimpel; V Daniel Castracane Journal: Am J Obstet Gynecol Date: 2002-11 Impact factor: 8.661
Authors: Susanne Tan; Susanne Hahn; Sven Benson; Tiina Dietz; Harald Lahner; Lars C Moeller; Markus Schmidt; Sigrid Elsenbruch; Rainer Kimmig; Klaus Mann; Onno E Janssen Journal: Eur J Endocrinol Date: 2007-11 Impact factor: 6.664
Authors: José A M Marcondes; Sylvia A Y Yamashita; Gustavo A R Maciel; Edmund C Baracat; Alfredo Halpern Journal: Gynecol Endocrinol Date: 2007-05 Impact factor: 2.260
Authors: Kelsey E S Salley; Edmond P Wickham; Kai I Cheang; Paulina A Essah; Nicole W Karjane; John E Nestler Journal: J Clin Endocrinol Metab Date: 2007-12 Impact factor: 5.958